The most expensive medical conditions in America

被引:163
作者
Druss, BG [1 ]
Marcus, SC
Olfson, M
Pincus, HA
机构
[1] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Publ Hlth, New Haven, CT 06520 USA
[3] Univ Penn, Sch Social Work, Philadelphia, PA 19104 USA
[4] New York State Psychiat Inst & Hosp, Dept Psychiat, New York, NY 10032 USA
[5] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
[6] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA
[7] Univ Pittsburgh, RAND, Pittsburgh, PA 15260 USA
关键词
D O I
10.1377/hlthaff.21.4.105
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This study uses a nationally representative survey to identify the most expensive conditions in the United States and to examine the association between spending and disability. The most expensive conditions at a population level were ischemic heart disease and motor vehicle accidents; at the per capita level they were respiratory malignancies. There was not a significant association between rank order of treatment costs and disability; the conditions with the greatest disability relative to expenditures were mood disorders, chronic obstructive pulmonary disease, and arthropathies. We use the findings to discuss the role for cost-of-illness and burden-of-disease estimates in setting priorities.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 19 条
[1]
BERK ML, 2001, HLTH AFFAIRS MAR, P9
[2]
Usefulness of US cost-of-illness studies in healthcare decision making [J].
Bloom, BS ;
Bruno, DJ ;
Maman, DY ;
Jayadevappa, R .
PHARMACOECONOMICS, 2001, 19 (02) :207-213
[3]
BROCK D, 2000, AM DISABILITIES IMPL
[4]
BROCK D, 2001, HLTH CARE SOCIAL JUS
[5]
Cohen JW, 1996, INQUIRY-J HEALTH CAR, V33, P373
[6]
RATIONING FAIRLY - PROGRAMMATIC CONSIDERATIONS [J].
DANIELS, N .
BIOETHICS, 1993, 7 (2-3) :224-233
[7]
SETTING HEALTH-CARE PRIORITIES IN OREGON - COST-EFFECTIVENESS MEETS THE RULE OF RESCUE [J].
HADORN, DC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (17) :2218-2225
[8]
KIRSCHSTEIN R, 2002, DIS SPECIFIC ESTIMAT
[9]
Burden of disease Implications for future research [J].
Michaud, CM ;
Murray, CJL ;
Bloom, BR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (05) :535-539
[10]
MININO A, 2001, 49 NATL VIT STAT, V49, P1